[EN] PYRROLIDINE IMINOSUGARS USED IN THE TREATMENT OF CYSTIC FIBROSIS<br/>[FR] IMINOSUCRES DE PYRROLIDINE UTILISÉS DANS LE TRAITEMENT DE LA MUCOVISCIDOSE
申请人:SUMMIT CORP PLC
公开号:WO2011086347A1
公开(公告)日:2011-07-21
A compound of formula (I) wherein: R1 is selected from H; linear or branched, substituted or unsubstituted alkyl, alkenyl, alkynyl and aralkyl and wherein the optional substitution may be with one or more groups independently selected from: -OH; -F; -Cl; -Br; -I; -NH2; alkylamino; dialkylamino; linear or branched alkyl, alkenyl, alkynyl and aralkyl; aryl; heteroaryl; linear or branched alkoxy; aryloxy; aralkoxy; -(alkylene)oxy(alkyl); -CN; -NO2; - COOH; -COO(alkyl); -COO(aryl); -C(O)NH(alkyl); -C(O)NH(aryl); sulfonyl; alkylsulfonyl; arylsulfonyl; sulfamoyl; alkylsulfamoyl; alkylthio; alkylsulfonamide; arylsulfonamide; -NHNH2; and -NHOH; or a bioisostere, pharmaceutically acceptable salt or derivative thereof, finds application in the treatment of cystic fibrosis.
化合物的化学式(I),其中:R1选自H;线性或支链、取代或未取代的烷基、烯基、炔基和芳基,其中可选的取代基可与一个或多个独立选择的基团取代,包括:-OH;-F;-Cl;-Br;-I;-NH2;烷基氨基;二烷基氨基;线性或支链烷基、烯基、炔基和芳基;芳基;杂环芳基;线性或支链烷氧基;芳氧基;芳基烷氧基;-(烷基)氧(烷基);-CN;-NO2;-COOH;-COO(烷基);-COO(芳基);-C(O)NH(烷基);-C(O)NH(芳基);磺酰基;烷基磺酰基;芳基磺酰基;磺胺基;烷基磺胺基;烷基硫基;烷基磺酰胺;芳基磺酰胺;-NHNH2;和-NHOH;或其生物同位素,药用盐或衍生物,在囊性纤维化的治疗中有应用。